- Home
- FULC vs DMB Comparison
FULC vs DMB Comparison
Compare FULC & DMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- DMB
- Stock Information
- Founded
- FULC 2015
- DMB 2013
- Country
- FULC United States
- DMB United States
- Employees
- FULC N/A
- DMB N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- DMB Trusts Except Educational Religious and Charitable
- Sector
- FULC Health Care
- DMB Finance
- Exchange
- FULC Nasdaq
- DMB Nasdaq
- Market Cap
- FULC 210.9M
- DMB 196.4M
- IPO Year
- FULC 2019
- DMB N/A
- Fundamental
- Price
- FULC $3.85
- DMB $10.78
- Analyst Decision
- FULC Hold
- DMB
- Analyst Count
- FULC 9
- DMB 0
- Target Price
- FULC $7.63
- DMB N/A
- AVG Volume (30 Days)
- FULC 368.1K
- DMB 76.6K
- Earning Date
- FULC 02-25-2025
- DMB 01-01-0001
- Dividend Yield
- FULC N/A
- DMB 4.17%
- EPS Growth
- FULC N/A
- DMB N/A
- EPS
- FULC N/A
- DMB N/A
- Revenue
- FULC $80,871,000.00
- DMB N/A
- Revenue This Year
- FULC $2,823.78
- DMB N/A
- Revenue Next Year
- FULC N/A
- DMB N/A
- P/E Ratio
- FULC N/A
- DMB N/A
- Revenue Growth
- FULC 2987.86
- DMB N/A
- 52 Week Low
- FULC $2.86
- DMB $8.94
- 52 Week High
- FULC $13.70
- DMB $11.79
- Technical
- Relative Strength Index (RSI)
- FULC 47.75
- DMB 66.58
- Support Level
- FULC $3.64
- DMB $10.60
- Resistance Level
- FULC $3.94
- DMB $10.75
- Average True Range (ATR)
- FULC 0.18
- DMB 0.09
- MACD
- FULC 0.02
- DMB 0.02
- Stochastic Oscillator
- FULC 84.21
- DMB 100.00
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About DMB BNY Mellon Municipal Bond Infrastructure Fund Inc.
BNY Mellon Municipal Bond Infrastructure Fund, Inc. is a diversified closed-end management investment company. The fund's investment objective is to provide as high a current income exempt from regular federal income tax as is consistent with the preservation of capital. It invests in transportation, energy and utilities, social infrastructure, and water and environmental sectors.